Furthermore, Kaplan-Meier analysis showed that the median survival times of GC patients with high and low TRPV1 expression were 63 and 22 months, respectively, indicating that the GC patients with high TRPV1 expression had a better prognosis, but those with low expression had a poor prognosis (P = 0.008, Fig. 1d). Here, TRPV1 is linked to gastric cancer.